Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Parallel Screening Approach for the Non-Invasive Delivery of Macromolecules
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: CHIN, William Wei Lim (Catalent Pharma Solutions, Science and Technolgoy, Eberbach, Germany)
- Co-author(s): Jan Neelissen: Science and Technology, Catalent Pharma Solutions, Eberbach, Germany
Vincent Plassat: Science and Technology, Catalent Pharma Solutions, Beinhein, France
William Wei Lim Chin: Science and Technology, Catalent Pharma Solutions, Eberbach, Germany
Stephen Tindal: Science and Technology, Catalent Pharma Solutions, Somerset, United States
BackgroundsThe OptiGel™ Bio is based on oral delivery of lipid formulation with permeation enhancement and the Zydis® Bio is based on orally disintegrating tablets for sublingual delivery of drugs.
AimsAn evaluation between these two Catelent’s proprietary technologies for oral delivery of macromolecules was conducted using a model compound, Salmon .. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019